arrow-positive PFE - Pfizer Inc. 25.08 -0.13 (-0.52%)

As of June 22, 2026 4:01 pm EDT
Add to Watchlist
Get new quote

Quote Detail

Last 25.08
Change -0.13
Change % -0.52
Bid 24.97 X 100
Ask 25 X 200
Volume 41.12 M
Shares 5.7 B
Market Cap 143.68 B
   
Open 25.22
High 25.31
Low 24.96
Prev Close 25.21
52 Wk High 28.75
52 Wk Low 23.11
EPS 1.3128
P/E 19.33
Div Yield 6.82

Market Headlines

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines 05/28/2026 07:01PM

SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 28, 2026 /PRNewswire via COMTEX News Network/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies...

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines 05/28/2026 06:59PM

SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 28, 2026 /PRNewswire via COMTEX News Network/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies...

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer 05/17/2026 07:09PM

Mar 19, 2026 (MarketLine via COMTEX News Network) -- Pfizer reported positive topline Phase 3 TALAPRO-3 results showing that TALZENNA (talazoparib) in combination with XTANDI (enzalutamide)...

BioMedNewsBreaks -- SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly 05/11/2026 10:14AM

May 11, 2026 (Investor Brand Network via COMTEX News Network) -- This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.